Reference is made to each of those certain Subscription Agreements, dated as of October 26, 2000 (the "Subscription Agreements") and the Modification ----------------------- Agreement, dated as of March 6, 2001, between each Subscriber and Kaire...Subscription Agreement • May 3rd, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
Exhibit 4.1 This Agreement (the "Agreement") is dated February 17, 2003 and is entered into by and between KAIRE HOLDINGS, INC. (hereinafter "KAHI" or "CLIENT") and George Lefevre and Scott Absher (otherwise known as NEOTACTIX, INC.) (hereinafter...Service Agreement • February 18th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
RECITALSAgreement and Plan of Reorganization • December 23rd, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances • Delaware
Exhibit 10.40 SECOND ADDENDUM TO AGREEMENT AND PLAN OF MERGER ----------------------------------------------- This SECOND ADDENDUM TO AGREEMENT AND PLAN OF MERGER is made this December 6, 2000, by and among Kaire Holdings, Incorporated, a Delaware...Agreement and Plan of Merger • March 20th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
1. Vote on Merger and Related Matters. The Constituent Corporations ------------------------------------- shall each, as soon as practicable, but prior to closing, and in no event later than 10 days after the execution and delivery hereof, (i) cause a...Acquisition Agreement • March 20th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • Nevada
CONSULTING AGREEMENT --------------------Consulting Agreement • July 18th, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances
Exhibit 4.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Warrant Agreement • August 27th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ---------------------------- 4.1(a) as amended 11,150,000Consulting Agreement • May 25th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 10.38 MODIFICATION AGREEMENT ---------------------- WHEREAS, as of October 26, 2000 and January 10, 2001, Kaire Holdings, Incorporated, a Delaware corporation (the "Company"), pursuant to Subscription Agreement dated October 26, 2000...Modification Agreement • March 20th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
Exhibit 10.34 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Warrant Agreement • December 13th, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 2.1 Offer for Purchase and Sale and receipt for deposit. This is a legally binding contract (please read carefully before signing) Received from Effective Heath, Inc. Date October 4 ,2002 ---------------------------------- -----------------...Purchase Agreement • January 30th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
ARTICLE IConvertible Note • August 27th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ----------------------------Consulting Agreement • October 15th, 1999 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
WITNESSETHConsulting Agreement • August 5th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
Exhibit 10.32 SUBSCRIPTION AGREEMENT ---------------------- Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Kaire Holdings Incorporated, a Delaware corporation (the "Company") hereby agrees to issue and to sell to the Subscriber,...Subscription Agreement • December 13th, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
SUBSCRIPTION AGREEMENTSubscription Agreement • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of June 23, 2005, by and among Kaire Holdings, Inc., a Delaware corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
ContractWarrant Agreement • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO KAIRE HOLDINGS INCORPORATED THAT SUCH REGISTRATION IS NOT REQUIRED.
Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ---------------------------- 4.1(a) 1,000,000 4.1(b) 1,000,000 4.1(c) 300,000 4.1(d) 1,000,000 4.1(e) 300,000 Other Consultants 1,350,000 Exhibit 4.1(a) CONSULTING AGREEMENT...Consulting Agreement • February 11th, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
WITNESSETHConsulting Agreement • February 18th, 2003 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
WITNESSETHConsulting Agreement • March 27th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Consulting Services Agreement (this “Agreement”) is dated August 31, 2016, and is entered into in Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China between YibaoConfucian Co., Ltd, with a registered address at Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Party A”), and Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China (“Party B”),. Party A and Party B are referred to collectively in this Agreement as the “Parties.”
CONVERTIBLE NOTEConvertible Note • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder, dated of even date herewith (the “Subscription Agreement”), and shall be governed by the terms of such Subscription Agreement. Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
SECURED CONVERTIBLE NOTESecured Convertible Note • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder, dated of even date herewith (the “Subscription Agreement”), and shall be governed by the terms of such Subscription Agreement. Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
ARTICLE 1. THE MERGERMerger Agreement • June 22nd, 2000 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • Delaware
WITNESSETHAcquisition Agreement • July 21st, 1997 • Interactive Medical Technologies LTD • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.42 ------------- SUBSCRIPTION AGREEMENT ---------------------- Dear Subscriber: You (the "Subscriber") hereby agree to purchase, and Kaire Holdings Incorporated, a Delaware corporation (the "Company") hereby agrees to issue and to sell to...Subscription Agreement • May 3rd, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances
EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Equity Pledge Agreement (hereinafter this “Agreement”) is dated August 31, 2016, and entered into in Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China by YibaoConfucian Co., Ltd, with a registered address Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Pledgee”), and each of the shareholders of Party B listed on the signature pages hereto (collectively, the “Pledgors”), and Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park, Yanzhou City, Jining, , Shandong, China (“Party B” or “Company”),
EMPLOYMENT AGREEMENTEmployment Agreement • December 8th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies • Nevada
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of December 1, 2016 by and between International Packaging and Logistics Group, Inc., Inc., a Nevada Company (the “Company”), and Xiuhua Song (the “Employee”).
ContractCommon Stock Purchase Warrant • September 8th, 2005 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO KAIRE HOLDINGS INCORPORATED THAT SUCH REGISTRATION IS NOT REQUIRED.
STOCK PURCHASE AGREEMENT BETWEEN XIUHUA SONGSHANDONG TBD CHINA COMPANY. And INTERNATIONAL PACKAGING AND LOGISTICS GROUP, INC. STANDARD RESOURCES LTD. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 11th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies • Nevada
THIS STOCK PURCHASE AGREEMENT, dated as of May 15, 2016, by and between Xiuhua Song (the “Buyer”), and TBD China Company (Shangdong Kangfusen Biotech Co. Ltd., a China Company or Shandong Yibao Biologics Co. LTD) and International Packaging and Logistics Group, Inc. (the “Seller”)(the “Company”) and Standard Resources Ltd.. As used herein, the term “Parties” shall be used to refer to the Buyer and the Seller, jointly.
ContractWarrant Agreement • June 21st, 2004 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO KAIRE HOLDINGS INCORPORATED THAT SUCH REGISTRATION IS NOT REQUIRED.
OPTION AGREEMENTOption Agreement • September 6th, 2016 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies
This Option Agreement (this “Agreement”) is entered into, as of August 31, 2016, in Xinglong Industry Park,Yanzhou City, Jining, Shandong, China by YibaoConfucian Co., Ltd, with a registered address at Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai, Hong Kong (“Party A”), Shangdong Confucian Biologics Co. Ltd., with a registered address at Xinglong Industry Park,Yanzhou City, Jining, Shandong, China (“Party B”), and each of the shareholders of Party B listed on the signature pages hereto (collectively, the “Party C”), Party A, Party B and Party C are referred to collectively in this Agreement as the “Parties.”
EMPLOYEE AGREEMENT INDEXEmployment Agreement • March 20th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • California
SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 26th, 2010 • International Packaging & Logistics Group Inc. • Wholesale-machinery, equipment & supplies • Nevada
This Share Purchase Agreement (the “Agreement”), dated as of January 1, 2010, is by and among International Packaging and Logistics Group Inc., a corporation organized under the laws of Nevada with principle executive offices located at 7700 Irvine Center Dr., Suite 870, Irvine, California 92618 (“IPL” or the “Buyer”), EZ Link Holdings, Ltd., company organized under the laws of the British Virgin Islands, with principle offices located at 2F., No.245, Sec. 2, Bade Rd., Zhongshan District, Taipei City 104, Taiwan, Republic of China (“EZ Link” or the “Company”), and the persons and/or entities listed on Exhibit A hereto who are the holders in the aggregate of all of the issued and outstanding capital shares of the Company (referred to collectively as the “Seller”) (Buyer, Company, and Seller may be referred to collectively as the “Parties”).
CONVERTIBLE NOTEConvertible Note Agreement • January 23rd, 2006 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
This Note has been entered into pursuant to the terms of a subscription agreement between the Borrower and the Holder, dated of even date herewith (the “Subscription Agreement”), and shall be governed by the terms of such Subscription Agreement. Unless otherwise separately defined herein, all capitalized terms used in this Note shall have the same meaning as is set forth in the Subscription Agreement. The following terms shall apply to this Note:
